# Final Implementation Report

Timestamp: 2026-10-11T17:06:00Z  
Branch: `cursor/software-completion-c293`  
Environment: isolated local + GitHub Actions  
Sales: locked (`BUZZARD_SALES_ENABLED` unset)  
Product SoT: inactive  
Production access: none

HEAD at documentation time is the commit that records this report. Implementation changes are in the same branch as PR #426.

## What was implemented in this pass

1. Canonical pricing now lifts sale price to cover landed cost + marketplace commission + VAT + **€0.50** net profit when those inputs are present. Negative shipping and invalid fee rates fail closed. `saleApproved` is false when the quote is incomplete. The €0.10 undercut remains unimplemented.
2. `pusat.cancelTask` cancels non-complete tasks deterministically, is idempotent, and records `sideEffects:false`. Completed tasks are not cancelled.
3. `software.providerDiagnostics.diagnose()` is a dry-run inventory. It never opens a network session, never writes, never enables sales, and rejects production URLs. CLI: `npm run diagnostics:providers`.
4. Admin `GET /api/admin/software/provider-diagnostics` requires auth + `ai.read`.
5. Targeted frontend patch: `next` and `eslint-config-next` **15.5.23 → 15.5.27** (Next RCE / cache-poisoning ranges `<15.5.24` / `<15.5.27`). Vitest 5 and sharp/postcss bundled by Next were **not** force-upgraded.

## What was verified without changing

Pusat idempotency, Guardian deny, approval bind/expire, memory restart, worker stale-lock recovery, sales lock, ACTIVE reject, storefront locale≠market, Arabic RTL, admin Control Center, PIM dry-run.

## Safety

No production deploy, no PR merge, no live probe, no commercial side effects. Local `/api/health` reported `salesEnabled:false` and `orders:0`.
